Final-Program-ATS-2023-AP.vp

178

MONDAY • MAY 22

P1011 Feasibility of Respiratory Therapy Device Three-dimensional Printing in Clinician Offices/ H.S. Sagoo, Willemstad, Curaçao P1012 Correlation of Subjective Perceived Activity and Weakness Score (PAWS) With Maximum Inspiratory Pressure (MIP), Maximum Expiratory Pressure (MEP) and Peak Inspiratory Flow Rate (PIFR)/ M.A. Valdes, Knoxville, TN P1013 Early COPD Diagnosis: Age, Smoking, and Ethnicity Factors/ J. Park, Corpus Christi, TX P1014 Validation of Body Composition by Bioelectrical Impedance Analysis for Chronic Respiratory Disease/ T. Muraoka, Yokohama, Japan P1015 The Changing Face of Community Respiratory Care/ M.C. Apps, Billericay, United Kingdom P1016 How Is the Endothelial Function Response to Non Invasive Ventilation in Hopitalised Patients With Chronic Obstructive Pulmonary Disease and Heart Failure Exacerbation/ E.Z. Kabbach, Sao Carlos, Brazil P1017 Post-ICU Syndrome in Extracorporeal Membrane Oxygenation Survivors Treated at a Long-Term Acute Care Hospital/ D.H. Tran, Baltimore, MD P1018 Use and Clinical Value of Whole Exam Sequencing in Patients With Severe Asthma/ K. Spaulding, New Haven, CT P1019 Trajectories of Quality of Life Following Home-based Pulmonary Rehabilitation in COPD Patients/ R. Benzo, Rochester, MN P1020 The Efficacy of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis/ J.H. Lee, Busan, Korea, Republic of

P995 Enrichment of Immune System Related Proteins in Circulating Extracellular Vesicles by Acute Exercise in Humans With and Without COPD/ A. Abbasi, Torrance, CA P996 Metabolic Changes in Donor Lung During Ischemia as a Function of Time and Temperature/ L. Loza, Philadelphia, PA P997 Current Status of Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease in South Korea/ H. Joo, Uijeongbu, Korea, Republic of P998 Pulmonary Hypertension Patient Perspectives Towards Pulmonary Rehabilitation/ M. Bailey, Rochester, MN P999 Patients With Acute Guillain-Barre Syndrome in Long-Term Acute Care/ K. Weil, Syracuse, NY P1000 Pilot Clinical Study on the Safety, Tolerance and Comfort of Thoracicvibratory Therapy by Electrostimulation. Phase 1. The Electrovest Study/ M.D.P. Cejudo Ramos, Seville, Spain P1001 Exploratory Efficacy Analysis of INSPIRE Open Label Extension Study With Inhaled Treprostinil (Yutrepia™)/ C.D. Burger, Jacksonville, FL P1002 High Levels of Comorbidity Are Strongly Associated With Mortality in Patients Enrolled in Pulmonary Rehabilitation/ A.J. Portillo, North Haven, CT P1003 Respiratory Symptoms, Health-Related Quality of Life, and Symptom Management in Ehlers-Danlos Syndrome and Generalized Hypermobility Spectrum Disorders/ N. Al Kaabi, Toronto, Canada P1004 Reference Equation ??for the Six-minute Walk Test in the Ecuadorian Population/ M.B. Noboa-Sevilla, Barcelona, Spain P1005 Home-based Pulmonary Rehabilitation and Health Coaching in Bronchiectasis/ C. Batzlaff, Rochester, MN P1006 Home Based Pulmonary Rehabilitation Delivered by a Newly Established Program Improves Dyspnea and Health Related Quality of Life in a Veteran Population/ D.A. Breiburg, Palo Alto, CA P1007 A Quality Improvement Process to Optimize Hybrid Rehabilitation Delivery for Lung Transplant Candidates/ L. Wickerson, Toronto, Canada P1008 Pleural Based Small Cell Carcinoma With Massive Pleural Effusion- A Rare Presentation/ R. Meenakshisundaram, Sayre, PA P1009 A Unique Course: A Case Report Of Anomalous Pulmonary Artery In An Adult With Asthma Exacerbation/ M. Owolabi, Newark, NJ P1010 Satisfaction With Virtual Pulmonary Rehabilitation for COPD Patients Using Peer Coaches/ A.C. Singh, Pittsburgh, PA

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

B65

IMMUNE AND ENDOTHELIAL CELLS HIT BACK AT LUNG REPAIR

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area L, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion 12:15-1:15 authors will be present for discussionwith assigned facilitators. P1242 Common and Distinct Bronchoalveolar Lavage and Lung Immune Signatures in Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis/ A.Y.-T. Zhao, New Haven, CT P1243 ScRNAseq Analysis of Lung Macrophage-fibroblast Crosstalk/ P. Yadav, San Francisco, CA

ATS 2023 • Washington, DC